【众生药业:已建立多模式研发生态体系,1个创新药获批上市】金融界2月17日消息,众生药业披露投资者关系活动记录表显示,公司已建立多模式良性循环的研发生态体系,重点聚焦代谢性疾病和呼吸系统疾病领域。目前,公司已有1个创新药项目获批上市,1个创新药项目的新药上市申请获得受理,多个创新药项目处于临床试验阶段。

金融界
17 Feb
金融界2月17日消息,众生药业披露投资者关系活动记录表显示,公司已建立多模式良性循环的研发生态体系,重点聚焦代谢性疾病和呼吸系统疾病领域。目前,公司已有1个创新药项目获批上市,1个创新药项目的新药上市申请获得受理,多个创新药项目处于临床试验阶段。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10